127 related articles for article (PubMed ID: 38114350)
21. Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study.
Rakauskas A; Peters M; Martel P; van Rossum PSN; La Rosa S; Meuwly JY; Roth B; Valerio M
PLoS One; 2023; 18(1):e0280262. PubMed ID: 36652429
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Prospectively Assigned Likert Scores for Targeted Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsies in Patients with Suspected Prostate Cancer.
Costa DN; Lotan Y; Rofsky NM; Roehrborn C; Liu A; Hornberger B; Xi Y; Francis F; Pedrosa I
J Urol; 2016 Jan; 195(1):80-7. PubMed ID: 26192254
[TBL] [Abstract][Full Text] [Related]
23. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.
Wegelin O; Exterkate L; van der Leest M; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
Eur Urol; 2019 Apr; 75(4):582-590. PubMed ID: 30522912
[TBL] [Abstract][Full Text] [Related]
24. Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review.
Valerio M; Donaldson I; Emberton M; Ehdaie B; Hadaschik BA; Marks LS; Mozer P; Rastinehad AR; Ahmed HU
Eur Urol; 2015 Jul; 68(1):8-19. PubMed ID: 25454618
[TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance imaging-guided targeted prostate biopsy: Comparison between computer-software-based fusion versus cognitive fusion technique in biopsy-naïve patients.
Yamada Y; Shiraishi T; Ueno A; Ueda T; Fujihara A; Naitoh Y; Hongo F; Ukimura O
Int J Urol; 2020 Jan; 27(1):67-71. PubMed ID: 31587386
[TBL] [Abstract][Full Text] [Related]
26. Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy: Detection Rate of Clinically Significant Prostate Cancer.
Pepe P; Garufi A; Priolo G; Pennisi M
Clin Genitourin Cancer; 2017 Feb; 15(1):e33-e36. PubMed ID: 27530436
[TBL] [Abstract][Full Text] [Related]
27. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
[TBL] [Abstract][Full Text] [Related]
28. Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance.
Tran GN; Leapman MS; Nguyen HG; Cowan JE; Shinohara K; Westphalen AC; Carroll PR
Eur Urol; 2017 Aug; 72(2):275-281. PubMed ID: 27595378
[TBL] [Abstract][Full Text] [Related]
29. Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted Biopsies.
Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Preisser F; Tilki D; Fisch M; Graefen M; Budäus L
J Urol; 2018 Nov; 200(5):1035-1040. PubMed ID: 29935274
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of transperineal software-assisted magnetic resonance/ultrasound fusion biopsy and transrectal cognitive fusion biopsy of the prostate.
Hsieh PF; Chang TY; Lin WC; Chang H; Chang CH; Huang CP; Yang CR; Chen WC; Chang YH; Wang YD; Huang WC; Wu HC
BMC Urol; 2022 Apr; 22(1):72. PubMed ID: 35488246
[TBL] [Abstract][Full Text] [Related]
31. Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy.
Garcia-Reyes K; Nguyen HG; Zagoria RJ; Shinohara K; Carroll PR; Behr SC; Westphalen AC
J Urol; 2018 Mar; 199(3):699-705. PubMed ID: 28941918
[TBL] [Abstract][Full Text] [Related]
32. Magnetic Resonance Imaging/Ultrasound Fusion-guided Transperineal Versus Magnetic Resonance Imaging/Ultrasound Fusion-guided Transrectal Prostate Biopsy-A Systematic Review.
Rai BP; Mayerhofer C; Somani BK; Kallidonis P; Nagele U; Tokas T
Eur Urol Oncol; 2021 Dec; 4(6):904-913. PubMed ID: 33478936
[TBL] [Abstract][Full Text] [Related]
33. Cost-Effectiveness Comparison of Imaging-Guided Prostate Biopsy Techniques: Systematic Transrectal Ultrasound, Direct In-Bore MRI, and Image Fusion.
Venderink W; Govers TM; de Rooij M; Fütterer JJ; Sedelaar JPM
AJR Am J Roentgenol; 2017 May; 208(5):1058-1063. PubMed ID: 28225639
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer.
Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D
J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846
[TBL] [Abstract][Full Text] [Related]
35. Prostate Mapping for Cancer Diagnosis: The Madrid Protocol. Transperineal Prostate Biopsies Using Multiparametric Magnetic Resonance Imaging Fusion and Micro-Ultrasound Guided Biopsies.
Rodríguez Socarrás ME; Gomez Rivas J; Cuadros Rivera V; Reinoso Elbers J; Llanes González L; Michel Mercado I; Fernandez Del Alamo J; Juarez Del Dago P; Sancha FG
J Urol; 2020 Oct; 204(4):726-733. PubMed ID: 32314932
[TBL] [Abstract][Full Text] [Related]
36. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.
Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S
BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210
[TBL] [Abstract][Full Text] [Related]
37. The Institutional Learning Curve of Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy: Temporal Improvements in Cancer Detection in 4 Years.
Meng X; Rosenkrantz AB; Huang R; Deng FM; Wysock JS; Bjurlin MA; Huang WC; Lepor H; Taneja SS
J Urol; 2018 Nov; 200(5):1022-1029. PubMed ID: 29886090
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of Magnetic Resonance Imaging/Ultrasound-guided Target Biopsy in Detecting Clinically Significant Prostate Cancer.
Kurokawa G; Mori K; Sasaki H; Nakano J; Takahashi Y; Iwatani K; Urabe F; Tsuzuki S; Koike Y; Sato S; Takahashi H; Miki K; Kimura T
Anticancer Res; 2024 Feb; 44(2):679-686. PubMed ID: 38307559
[TBL] [Abstract][Full Text] [Related]
40. Minimum Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Cores Needed for Prostate Cancer Detection: Multivariable Retrospective, Lesion Based Analyses of Patients Treated with Radical Prostatectomy.
Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Tian Z; Karakiewicz PI; Tilki D; Fisch M; Maurer T; Graefen M; Budäus L
J Urol; 2020 Feb; 203(2):299-303. PubMed ID: 31483694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]